SAN DIEGO, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)APPLIED BIOMEDICAL SCIENCE INSTITUTE, founded in 2018, is a community nonprofit in the Medical Research sector that reported $4.5M in total revenue in fiscal year 2024. Revenue grew 11% year-over-year, indicating healthy expansion. Expenses of $4.3M left a modest 6% surplus.
TO PROMOTE AND PERFORM BIOMEDICAL RESEARCH TO ADVANCE THE UNDERSTANDING AND TREATMENT OF UNDERSERVED MEDICAL CONDITIONS.
THE APPLIED BIOMEDICAL SCIENCE INSTITUTE (AKA ABS INSTITUTE) IS FORMED TO PROMOTE AND PERFORM BIOMEDICAL RESEARCH INVOLVING BIOLOGICAL MECHANISMS OF DISEASE PATHOGENESIS AND RESOLUTION. THE INSTITUTE...
THE APPLIED BIOMEDICAL SCIENCE INSTITUTE (AKA ABS INSTITUTE) IS FORMED TO PROMOTE AND PERFORM BIOMEDICAL RESEARCH INVOLVING BIOLOGICAL MECHANISMS OF DISEASE PATHOGENESIS AND RESOLUTION. THE INSTITUTE WILL PERFORM BASIC AND TRANSLATIONAL BIOMEDICAL RESEARCH, INCLUDING MOLECULAR, GENETIC, CELLULAR, AND PHYSIOLOGICAL STUDIES, AND PUBLISH ITS RESULTS IN PUBLICLY ACCESSIBLE PEER REVIEWED PUBLICATIONS, AS WELL AS PRESENTATIONS AT NATIONAL AND INTERNATIONAL SCIENTIFIC MEETINGS AND CONFERENCES. THE INSTITUTE PROMOTES THERAPEUTIC TRANSLATION THROUGH INTERNAL RESEARCH, COLLABORATIONS, OR LICENSING ACTIVITIES OF ITS RESEARCH FINDINGS OR INTELLECTUAL PROPERTY. THE INSTITUTE TRAINS EARLY STAGE RESEARCHERS IN BIOMEDICAL RESEARCH THROUGH POST-DOCTORAL FELLOW AND INTERNSHIP PROGRAMS. A PART OF THE INSTITUTE'S ACTIVITIES WILL BE TO PROMOTE EDUCATION AND PROVIDE RESOURCES THROUGH ITS WEBSITE.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $4,539,463 | $4,081,942 | +0.1% |
| Expenses | $4,281,826 | $4,101,586 | +0.0% |
| Net Income | $257,637 | $-19,644 | -14.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| VAUGHN SMIDER | PRESIDENT | 40.00 |
Officer
Director
|
$146,222 | $15,234 | $161,456 |
| RONALD MARTELL | BOARD MEMBER | 1.50 |
Director
|
$0 | $0 | $0 |
| JAMES LARRICK | BOARD MEMBER | 1.50 |
Director
|
$0 | $0 | $0 |
| DAVID RABUKA | BOARD MEMBER | 1.50 |
Director
|
$0 | $0 | $0 |
| PETER SLOVER | CHIEF FINANICAL OFFICER | 10.00 |
Officer
|
$30,950 | $0 | $30,950 |
| MARILYN DIAZ | ASSOCIATE PROFESSOR | 40.00 |
Key Emp
|
$155,498 | $21,007 | $176,505 |
| LAURENT VERKOCZY | PROFESSOR | 40.00 |
Key Emp
|
$223,011 | $0 | $223,011 |
| DUNCAN MCGREGOR | VICE PRESIDENT, RESEARCH | 40.00 |
Highest
|
$122,412 | $15,816 | $138,228 |
| CHARLES MELANCON | DIRECTOR OF CHEMICAL BIOLO | 40.00 |
Highest
|
$108,298 | $21,007 | $129,305 |
| RUIQI HUANG | RESEARCH FELLOW | 40.00 |
Highest
|
$109,091 | $17,425 | $126,516 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $4,539,463 | $4,281,826 | $2,583,136 | $257,637 |
| 2023 | $4,081,942 | $4,101,586 | $2,783,859 | $-19,644 |
| 2022 | $3,480,044 | $3,496,560 | $2,861,100 | $-16,516 |
| 2021 | $2,682,413 | $2,578,837 | $1,308,035 | $103,576 |
| 2020 | $1,425,569 | $1,101,932 | $871,362 | $323,637 |
| 2019 | $808,396 | $821,276 | $531,581 | $-12,880 |
| 2018 | $422,367 | $139,530 | $289,315 | $282,837 |
Compare APPLIED BIOMEDICAL SCIENCE INSTITUTE with other nonprofits in California and across the country.